ImQuest Submits Investigational New Product Application To The Food And Drug Administration To Initiate HIV Therapeutic Clinical Trials With IQP-0410
ImQuest Life Sciences announced the successful submission of an IND application to the Food and Drug Administration to initiate human clinical trials for their lead pyrimidinedione HIV inhibitor IQP-0410. ImQuest anticipates initiating their Phase 1 studies in the first quarter of 2009. IQP-0410 is a novel small molecule inhibitor of HIV which primarily acts as a nonnucleoside reverse transcriptase inhibitor (NNRTI).ImQuest Submits Investigational New Product Application To The Food And Drug Administration To Initiate HIV Therapeutic Clinical Trials With IQP-0410
FDA Approves First Nucleic Acid Test To Screen For Additional Types Of HIV In Donated Blood And Tissue
The U.S. Food and Drug Administration approved the cobas TaqScreen MPX Test, the first nucleic acid test that screens for the presence of two divergent types of HIV in donated blood plasma and tissue. "With the MPX test, blood donor testing laboratories will be able to use nucleic acid technology to screen for additional HIV strains, further assuring that donated blood and tissue are free from infection and providing better protection for patients," said Jesse L. Goodman, M.D.FDA Approves First Nucleic Acid Test To Screen For Additional Types Of HIV In Donated Blood And Tissue
Differentiating Between Healthy Cells And Cancer Cells
One of the current handicaps of cancer treatments is the difficulty of aiming these treatments at destroying malignant cells without killing healthy cells in the process. But a new study by McMaster University researchers has provided insight into how scientists might develop therapies and drugs that more carefully target cancer, while sparing normal healthy cells Mick Bhatia, scientific director of the McMaster Stem Cell and Cancer Research Institute in the Michael G.Differentiating Between Healthy Cells And Cancer Cells
Health Care Spending in U.S. Grew at Lowest Rate in a Decade (HealthDay)
HealthDay - TUESDAY, Jan. 6 (HealthDay News) -- Due to slower spending on prescription drugs, health-care spending in the United States grew at the lowest rate in a decade in 2007, a new federal report found.Health Care Spending in U.S. Grew at Lowest Rate in a Decade (HealthDay)
Efforts To Curb HIV Among Drug Users In Vietnam Show Success, Still Face Challenges
The Vietnamese government's efforts to increase access to HIV/AIDS prevention and treatment programs among injection drug users are showing success, the Wall Street Journal reports. According to the Journal, the country is attempting to bolster public education and aid efforts targeted at high-risk groups, including IDUs.Efforts To Curb HIV Among Drug Users In Vietnam Show Success, Still Face Challenges
Prolonged Nevirapine In Breast-Fed Babies Prevents HIV Infection But Leads To Drug-Resistant HIV
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.Prolonged Nevirapine In Breast-Fed Babies Prevents HIV Infection But Leads To Drug-Resistant HIV
Coming Down on Tobacco
The new Congress plans to move aggressively against the tobacco industry by regulating cigarettes, raising sales taxes and ratifying an international antitobacco treaty.Coming Down on Tobacco
Spending Rise for Health Care and Prescription Drugs Slows
National health spending grew in 2007 at the lowest rate in nine years, mainly because prescription drug spending increased at the slowest pace since 1963.Spending Rise for Health Care and Prescription Drugs Slows
For Privacy’s Sake, Taking Risks to End Pregnancy
Some Latina women are using drugs or potentially harmful home methods to end their pregnancies.For Privacy’s Sake, Taking Risks to End Pregnancy
Morning Rounds: Taxing Sodas, Fitness Discounts and Conflicted Pharmacists
Health news from around the Web..Morning Rounds: Taxing Sodas, Fitness Discounts and Conflicted Pharmacists
No Mug? Drug Makers Cut Out Goodies for Doctors
The pharmaceutical industry has agreed to a voluntary moratorium on branded promotional items.No Mug? Drug Makers Cut Out Goodies for Doctors
Psychiatrist to Curtail Industry-Funded Activities
Dr. Joseph Biederman of Harvard will forgo speaking engagements and research as an investigation into drug maker fees unfolds.Psychiatrist to Curtail Industry-Funded Activities
The Evidence Gap: Genetic Tests Offer Promise of Personalized Medicine
Experts say that most drugs, whatever the disease, work for only about half the people who take them.The Evidence Gap: Genetic Tests Offer Promise of Personalized Medicine
The Year in Health & Medicine
The fitness pill, tainted drugs, why you should lick your wounds, and more.The Year in Health & Medicine
VITROS(R) 3600 Immunodiagnostic System For Laboratory Diagnostics Receives 510(k) Clearance From The FDA
Ortho Clinical Diagnostics announced 510(k) clearance from the United States Food and Drug Administration (U.S. FDA) for its VITROS(R) 3600 Immunodiagnostic System. This new high-capacity immunoassay system provides laboratories with a truly innovative solution to address their quality, labor and cost challenges. The VITROS(R) 3600 delivers high-quality and dependable results by offering a broad and comprehensive immunoassay menu based on world-class VITROS(R) technologies.VITROS(R) 3600 Immunodiagnostic System For Laboratory Diagnostics Receives 510(k) Clearance From The FDA
Business Involvement In Global HIV/AIDS Efforts Increasing, Economist Reports
As medical advances against HIV/AIDS have "somewhat stalled" since the development of antiretroviral drugs, "there are at least signs of growing awareness" from the "unexpected quarter" of the business world, the Economist reports.Business Involvement In Global HIV/AIDS Efforts Increasing, Economist Reports
Needle/Syringe Programmes And Opioid Substitution Therapy Should Be Widely Available In Prisons To Help Prevent HIV Transmission
Prisons should have needle and syringe programmes (NSPs), opioid substitution therapy (OST) and other preventive measures in place to prevent HIV transmission between inmates. These are the conclusions of a Review published in the January edition of Lancet Infectious Diseases, written by Dr Ralf Jürgens, a consultant for HIV/AIDS based in Quebec, Canada, and colleagues on behalf of WHO.Needle/Syringe Programmes And Opioid Substitution Therapy Should Be Widely Available In Prisons To Help Prevent HIV Transmission
F.D.A. to Reconsider Plastic Bottle Risk
The agency was accused of failing to adequately consider research about the dangers of a substance known as bisphenol-A.F.D.A. to Reconsider Plastic Bottle Risk
EDM Conference To Address Challenges And Realize Benefits Of Electronic Document Management
Unravel and clarify how both document/information management and submission technology play a central role in the pathway from research to submission at the Drug Information Association's (DIA's) 22nd Annual DIA Conference for Electronic Document Management (February 10-13; Philadelphia, PA).EDM Conference To Address Challenges And Realize Benefits Of Electronic Document Management
$6 Million Study Will Seek To Break Cycle Of Chemical Dependence And Incarceration
After serving time, prisoners battling heroin addiction, mental illness and HIV face many challenges as they re-enter society. As part of an effort to make this transition easier on both the prisoner and the community, researchers at the Yale University AIDS Program will study HIV prevention and drug treatment in soon-to-be released prisoners in Connecticut and Malaysia with funding from federal grants totaling $6.4 million.$6 Million Study Will Seek To Break Cycle Of Chemical Dependence And Incarceration
ZOLL Receives Clearance To Market R Series Code-Ready Defibrillator With WiFi Option
ZOLL Medical Corporation (Nasdaq GS: ZOLL), a manufacturer of resuscitation devices and related software solutions, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the ZOLL R Series® Code-Ready® clinical defibrillator with a WiFi option that allows wireless communication between the defibrillator and standard hospital networks to help ensure code-readiness and download patient data. Based on standard 802.ZOLL Receives Clearance To Market R Series Code-Ready Defibrillator With WiFi Option
FDA Warns About Weight Loss Products (HealthDay)
HealthDay - MONDAY, Dec. 22 (HealthDay News) -- The U.S. Food and Drug Administration warned consumers Monday to avoid more than two dozen products marketed for weight loss because they contain undeclared ingredients that could pose serious health risks.FDA Warns About Weight Loss Products (HealthDay)
The Evidence Gap: Drug Rehabilitation or Revolving Door?
In the costly world of addiction treatment, states are demanding programs show results. The jury is still out.The Evidence Gap: Drug Rehabilitation or Revolving Door?
A Conversation With Mahmoud A. Elsohly: Growing Marijuana With Government Approval
How do you become the man who grows all of the marijuana for government-funded studies?A Conversation With Mahmoud A. Elsohly: Growing Marijuana With Government Approval
Malaria Drug May Soon Be Set for U.S. Debut
The F.D.A. is set to approve the first malaria drug to contain a wormwood derivative - a popular treatment for the disease in Africa and Asia.Malaria Drug May Soon Be Set for U.S. Debut
Drug Shields Mice From Emphysema (HealthDay)
HealthDay - MONDAY, Dec. 22 (HealthDay News) -- In experiments in mice, scientists have shown that a new drug may protect the animals from the respiratory damage caused by cigarettes.Drug Shields Mice From Emphysema (HealthDay)
#3: The FDA Tackles Tainted Drugs From China
Globalization can have its price, as the U.S. found out this year—after countless scandals involving tainted food and drugs from China.#3: The FDA Tackles Tainted Drugs From China
#11: Effective Kidney Transplants Without a Lifetime of Powerful Drugs
Surviving an organ transplant is a tricky—and dangerous—business. But now a new discovery may help patients survive without the usual extensive drug regimens.#11: Effective Kidney Transplants Without a Lifetime of Powerful Drugs
Medical Publisher to Review Claim About Article’s Writer
Elsevier said it will investigate an allegation that one of its journals published an article that was ghostwritten by a drug company.Medical Publisher to Review Claim About Article’s Writer
#18: Two Alzheimer’s Drugs Show Promise
The race to find a treatment for Alzheimer’s now has two promising contestants, both unconventional drugs that are showing strong results—though the tests are still in early stages.#18: Two Alzheimer’s Drugs Show Promise